Updates and insight on the MS-STAT2 study from the team at UCL. A phase 3 clinical trial of high dose simvastatin for secondary progressive multiple sclerosis

ID: 1112656780272828416

linkhttp://www.ms-stat2.info calendar_today01-04-2019 10:03:43